Detection of integrin-linked kinase in the serum of patients with malignant pleural mesothelioma
✍ Scribed by Stefan B. Watzka; Florian Posch; Harvey I. Pass; Margaret Huflejt; David Bernhard; Gregory E. Hannigan; Michael R. Müller
- Book ID
- 113764647
- Publisher
- CTSNet
- Year
- 2011
- Tongue
- English
- Weight
- 141 KB
- Volume
- 142
- Category
- Article
- ISSN
- 1097-685X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo
## Abstract ## BACKGROUND. Promising results with trimodality therapy combining surgery, chemotherapy, and radiotherapy have been obtained in the management of patients with malignant pleural mesothelioma (MPM). However, the histologic subtype has to be taken into account because of its influence